PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark

C Purdy, P M Bytzer, M.M. Pimentel, R Magar

Original languageEnglish
JournalValue in Health
Volume18
Issue number7
Pages (from-to)A350
ISSN1098-3015
DOIs
Publication statusPublished - Nov 2015

Keywords

  • Journal Article

Cite this